Mr. Lowe has been in the financial services industry since 1999. He specializes in Independent Financial Services and Wealth Management through LPL Financial. Mr. Lowe started his career at Moors & Cabot Inc, before joining Wheat First Securities. Working at Wachovia for five years, Mr. Lowe partnered with a team that specialized in working with international organizations such as the World Bank, the IMF – International Monetary Fund, and the OAS – Organization of American States. In 2005, he left Wachovia and joined Ryan Beck which later became Stifel Nicolaus. In August of 2009, Mr. Lowe joined XML Financial Group, a wealth management firm located in Rockville, MD, which works with individuals, corporations and non-profit organizations. Mr. Lowe sits on the Community Leadership Board for the American Diabetes Association Washington, DC. He is the founding member and Chairman of the Board for the TJ – JL Foundation Inc., a local 501c3 raising money and awareness to combat diabetes. Jon is an active member of the Montgomery County Chamber of Commerce. Mr. Lowe is a board member for the C.L.A.Y. Foundation, a non-profit organization helping to prevent child drowning. Jon sat on the board for JUST TRYAN IT (helping kids with Cancer). Mr. Lowe volunteers regularly for such groups as the JDRF – Juvenile Diabetes Research Foundation, The DRWF – Diabetes Research Wellness Foundation, the Joslin Diabetes Center, and SOME (so others may eat). Jonathan’s a parishioner at Holy Redeemer Parish and is an active member of the Knights of Columbus, Rock Creek Council. Jon attended East Carolina University, concentrating his studies in Business and Finance. Jon resides in Kensington, MD with his family and spends his spare time being a dad, coaching and playing sports with his kids.
Harold M. Silverman, Pharm. D.
Dr. Harold Silverman has been practicing health care, public affairs, and communications since 1987. He is currently an author and has operated a medical/scientific affairs consultancy in Silver Spring, MD since 2002. Dr. Silverman’s range of experience includes regulatory, legislative, and corporate issues as well as crisis counseling, working with the media, developing presentations and congressional testimony training. He also has extensive experience in product promotion as well as scientific and educational program development for the pharmaceutical/medical device industries, professional associations, and government entities such as the National Institutes of Health.
Dr. Silverman’s regulatory and issues experience includes health care reform, conflicts of interest in medical research, drug utilization reviews, and FDA reformation. He has been counsel on new drug approvals and has worked on other issues of direct interest to pharmaceutical, device and health care clients. He has designed and supervised marketing communications programs and counseled many clients on preventing and managing a variety of different legal and other crises.
Dr. Silverman has worked in a great many clinical areas including gene therapy and genomics, arthritis, cardiovascular medicine, oncology, pulmonary medicine, AIDS, anti-infective agents, antithrombosis, and medical imaging. Some specific activities performed on behalf of clients include research promotion, pre-launch and launch programs, post-marketing communications, continuing education symposia, sales force training, and FDA relations. Silverman was the principal external consultant to Sanofi and Bristol Myers-Squibb for their Plavix (clopidogrel) FDA CardioRenal Drugs Advisory Committee meeting preparation.
Dr. Silverman was Medical Director and Senior Vice President at Manning, Selvage & Lee, Vice Chairman of InterScience, (a global healthcare public affairs consultancy), and was Senior Vice President at Hill and Knowlton in Washington, DC. He has been president of the National Association of Pharmaceutical Manufacturers, an association of generic pharmaceutical companies and director of technical services at Bard MedSystems, a Division of CR Bard.